Floatz logo

TESTOSTERONE UNDECYLATE

Musculoskeletal Complications

Alliance for Clinical Trials in OncologySmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Musculoskeletal Complications cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Stanford University
Phase 4BB
Tirzepatide
Pennington Biomedical Research Center
Phase 4BB
L-Ofloxacin
Children's Oncology Group
Phase 3BB
Duloxetine
SWOG Cancer Research Network
Phase 3BB
Naproxen
Gary Morrow
Phase 3BB

View all 19 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

hypogonadotropic hypogonadismDormant
A
Indicative ·
82 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →